Compare Air Products & Chemicals, Inc. (APD) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Air Products & Chemicals, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? Air Products & Chemicals, Inc. trades at $308.56 (market cap $68.88B), while State Street SPDR S&P Biotech ETF trades at $158.28. The key difference: Air Products & Chemicals, Inc. pays a 2.34% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| APD | XBI | |
|---|---|---|
Market Cap | $68.88B | — |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $314.19 | $164.28 |
52-Week Low | $230.42 | $86.92 |
Enterprise Value | $86.06B | — |
Dividend Yield | 2.34% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Air Products & Chemicals, Inc.
Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the largest supplier of hydrogen and helium in the world. It has a unique portfolio serving customers in a number of industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated $10.3 billion in revenue in fiscal 2021.
Read more on APD →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
